Engelsk titel: Acute myelogenous leukemia and myelodysplastic syndrome after treatment with cytostatic agents
Läs online
Författare:
Abrahamsen AF
Språk: Nor
Antal referenser: 38
Dokumenttyp:
Översikt
UI-nummer: 00091656
Sammanfattning
INTRODUCTION : The introduction of high dose chemotherapy of cancer has been followed by an increased incidence of therapy-related acute myeloid leukaemia and myelodysplastic syndrome.
MATERIAL AND METHODS : A survey of the literature has shown that these complications have been attributed to a high accumulated dose of alkylating agents, antracyclins and epipodophyllotoxins. The incidence increases after additional irradiation.
RESULTS : After standard doses of leukaemogenic drugs the incidence of acute myeloid leukaemia and myelodysplastic syndrome is reported to be 0-4%, increasing to 8-10% after high dose therapy. At diagnosis of acute myeloid leukaemia and myelodysplastic syndrome, most of the patients have chromosomal abnormalities.
INTERPRETATION : The prognosis of therapy-related acute myeloid leukaemia and myelodysplastic syndrome is poor compared to that in primary acute myeloid leukaemia and myelodysplastic syndrome.